Search results

20 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Triple-Negative Breast Cancer: Still A Hard Fight For African-American Women
Keith Amos, MD, quoted in The Huffington Post
Located in News / 2011 News
Combination therapy for triple-negative breast cancer disappointing
CHAPEL HILL, N.C. – A recent clinical trial testing a combination therapy for basal-like (also known as triple-negative) breast cancer demonstrates that a combination of two drugs with promising preclinical results is not as effective as researchers had hoped.
Located in News / 2012 News
UNC surgeons co-author study on breast cancer treatment decision making
Chapel Hill, NC - How much medical information does a woman understand and retain about her breast cancer diagnosis? UNC scientists participated in a four-institution study involving 440 women with early-stage breast cancer and found that breast cancer survivors had limited knowledge about their surgical options, including an understanding of something as important as the risk of recurrence.
Located in News / 2012 News
UNC scientist receives grant to identify biomarkers for breast cancer recurrence risk
Chapel Hill - A UNC scientist was awarded one of seven grants presented by the Avon Walk for Breast Cancer at their seventh annual event in Charlotte, NC.
Located in News / 2011 News
Amos discusses breast cancer in the black community on Black Issues Forum
Keith Amos, MD, FACS, was interviewed by UNC-TV’s Black Issues Forum on community education about breast cancer in the African American community on Sunday, Oct. 28.
Located in News / 2012 News
Causes of African-American breast cancer incidence study receives $19.3M: UNC partners to form largest US database
Chapel Hill - UNC scientist Robert Millikan will partner with Christine Ambrosone, of Roswell Park Cancer Institute, and Julie R. Palmer, of Boston University, in the most ambitious study to date of breast cancer among younger African-American women.
Located in News / 2011 News
UNC Lineberger geriatric oncology program leaders co-author Journal of Clinical Oncology editorial about older women and breast cancer
UNC Lineberger Geriatric Oncology program leaders Hy Muss, MD, and Jan Busby-Whitehead, MD, co-authored an editorial in the December 10, 2011 issue of the Journal of Clinical Oncology. Muss is professor of medicine. Busby-Whitehead is professor of medicine, and director of the UNC School of Medicine’s Center for Aging and Health and Division of Geriatric Medicine.
Located in News / 2012 News
UNC study looks at dose levels of the breast cancer drug, tamoxifen
Using a patient’s genetic information can be successfully used to manage the drug concentrations of tamoxifen, a drug used to treat and prevent breast cancer.
Located in News / 2011 News
Dr. Lisa Carey authors editorial on neoadjuvant trials for breast cancer
Lisa Carey, MD, authored an editorial, titled “Neoadjuvant Trials of Human Epidermal Growth Factor Receptor 2 Targeting: How Many Drugs Do We Need?”
Located in News / 2012 News
Study quantifies false positives for yearly mammograms
Breast Cancer Surveillance Consortium also compares digital and film mammography
Located in News / 2011 News